¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Granulocyte Precursor Cells"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® granulocyte ÇÑ±Û °ú¸³±¸
¼³¸í   
  °ú¸³±¸¶õ ÀûÇ÷±¸¸¦ Á¦¿ÜÇÑ Ç÷¾×¼ÓÀÇ ¼¼Æ÷ÀΠ¹éÇ÷±¸ÀÇ 60%¸¦ Â÷ÁöÇϸç, ¼¼Æ÷¼Ó¿¡ Æ¯ÀÌÇÑ °ú¸³À» °¡Áö°í Àִ ¼¼Æ÷À̸ç, ´ÙÀ½°ú °°Àº 3°¡ÁöÀÇ ¼¼Æ÷°¡ À̰÷¿¡ Æ÷ÇÔÀÌ µÈ´Ù.
  
  1. È£¿°±â±¸(basophil)-¿°±â¼º ¿°»ö¾à¿¡ Àß ¿°»öÀÌ µÇ´Â °ú¸³À» °¡Áö°í ÀÖ´Ù. ºÒ±ÔÄ¢ÇÑ ¸ð¾çÀÇ ¼¼Æ÷·Î Çª¸¥»öÀ» ¶ì´Â °ú¸³ÀÌ ³Ê¹« ¸¹ÀÌ À־ ÇÙÀÌ Àß º¸ÀÌÁö ¾Ê´Â´Ù.
  
  2. È£»ê±¸(eosinophil)-»ê¼º ¿°»ö¾à¿¡ Àß ¿°»öÀÌ µÇ´Â °ú¸³À» °¡Áö°í ÀÖ°í, ´ë°³ ±â»ýÃæÀÇ °¨¿°À̳ª, ¾Ë·¹¸£±â¿¡¼­ ¸¹ÀÌ Áõ°¡¸¦ ÇÑ´Ù. ´ë°³ 2°³ÀÇ ÇÙÀ» °¡Áö°í ÀÖÀ¸¸ç ÇÙ»çÀÌ¿¡ °¡´Â ½Ç°°Àº °ÍÀ¸·Î À̾îÁ® ÀÖ´Ù.
  
  3. È£Áß±¸(neutrophil)-»ê¼º ¿°»ö¾àÀ̳ª ¿°±â¼º ¿°»ö¾àÀ̳ª ¸ðµÎ Àß µÇ´Â °ú¸³À» °¡Áö´Â ¼¼Æ÷·Î ´ë°³ 3°³ÀÇ ÇÙÀ» °¡Áø´Ù. ±×¸®°í ÇÙ »çÀÌ¿¡ °¡´Â ½Ç°°Àº ±¸Á¶¹°ÀÌ À־ ÇÙÀ» ¼­·Î À̾îÁÖ°í ÀÖ´Ù.
  
  ÀÌ °ú¸³±¸´Â ÁַΠ¸é¿ª¿¡ °ü°èµÈ ¿ªÇÒÀ» Çϴ °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ´Ù. 
¿µ¹® segmented granulocyte ÇÑ±Û ºÐÀý °ú¸³±¸
¼³¸í   
  °ú¸³±¸(¼¼Æ÷Áú³»¿¡ Á¡°°Àº °ú¸³À» Æ÷ÇÔÇϴ ¼¼Æ÷)Áß ¸»ÃÊ Ç÷¾×À» ¼øÈ¯Çϴ ¼º¼÷µÈ °ú¸³±¸·Î ÇÙÀÇ ¸ð¾çÀÌ µÎ °³ ÀÌ»óÀÇ ºÐÀýÀ» ÀÌ·ç°í ÀÖ´Ù. ¿©±â¿¡´Â ±× ¿°»ö»óÀÇ ¹æ¹ý¿¡ µû¶ó È£Áß±¸(Áß¼º¿¡¼­ °ú¸³¿°»öÀ» º¸ÀÓ), È£»ê±¸(»ê¼º¿¡¼­ °ú¸³¿°»öÀ» º¸ÀÓ), È£¿°±¸(¿°±â¼º¿¡¼­ °ú¸³¿°»öÀ» º¸ÀÓ)·Î ³ª´¶´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • atypical glandular cells of undetermined significance
    Àǹ̹̰áÁ¤ºñÁ¤Çü»ù¼¼Æ÷
  • atypical squamous cells of undetermined significance
    Àǹ̹̰áÁ¤ºñÁ¤ÇüÆíÆò¼¼Æ÷
  • enzyme precursor
    È¿¼ÒÀü±¸¹°Áú
  • precursor
    Àü±¸¹°Áú
  • basophilic granulocyte
    È£¿°±â°ú¸³¹éÇ÷±¸, È£¿°±â°ú¸³±¸
  • granulocyte
    °ú¸³¹éÇ÷±¸, °ú¸³±¸
  • granulocyte colony-stimulating factor
    °ú¸³±¸Áý¶ôÀÚ±ØÀÎÀÚ
  • granulocyte-erythrocyte antigen
    °ú¸³±¸ÀûÇ÷±¸Ç׿ø
  • granulocyte-macrophage colony-stimulating factor
    °ú¸³±¸Å«Æ÷½Ä¼¼Æ÷Áý¶ôÀÚ±ØÀÎÀÚ, °ú¸³±¸´ë½Ä±¸Áý¶ôÀÚ±ØÀÎÀÚ
  • granulocyte-monocyte antigen
    °ú¸³±¸´ÜÇÙ±¸Ç׿ø
  • granulocyte-specific antigen
    °ú¸³±¸Æ¯ÀÌÇ׿ø
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • precursor
    Àü±¸¹°Áú
  • granulocyte
    °ú¸³¹éÇ÷±¸
  • basophilic granulocyte
    È£¿°±â°ú¸³¹éÇ÷±¸
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • enzyme precursor
    È¿¼ÒÀü±¸Ã¼
  • precursor
    Àü±¸¹°Áú
  • granulocyte-erythrocyte antigen
    °ú¸³±¸ÀûÇ÷±¸Ç׿ø
  • granulocyte-monocyte antigen
    °ú¸³±¸´ÜÇÙ±¸Ç׿ø
  • granulocyte-specific antigen
    °ú¸³±¸Æ¯ÀÌÇ׿ø
  • granulocyte colony-stimulating factor
    °ú¸³±¸Áý¶ôÀÚ±ØÀÎÀÚ
  • granulocyte-macrophage colony-stimulating factor
    °ú¸³±¸Å«Æ÷½Ä¼¼Æ÷Áý¶ôÀÚ±ØÀÎÀÚ
  • granulocyte
    °ú¸³¹éÇ÷±¸
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • abnormal localization of immature precursor cells=ALIP
    ¹Ì¼º¼÷Àü±¸¼¼Æ÷ÀÇ ºñÁ¤»ó ±¹Àç
  • DNA precursor
    DNA Àü±¸Ã¼, -¹°Áú
  • inactive precursor
    ºñȰ¼º Àü±¸¹°Áú.
  • JG cells = juxtaglomerular cells
    »ç±¸Ã¼¿±¼¼Æ÷(Þêϳô÷ç¨á¬øà)
  • G-CSF (Granulocyte colony-stimulating factor)
    °ú¸³¼¼Æ÷±ºÃËÁøÀÎÀÚ(Î¨Ø£á¬øàÏØõµòäì×í­)
  • granulocyte
    °ú¸³¹éÇ÷__¡­ÛÜúìϹ), °ú¸³__
  • granulocyte
    °ú¸³±¸
  • granulocyte colony-stimulating factor
    °ú¸³±¸Áý¶ôÀÚ±ØÀÎÀÚ
  • granulocyte colony-stimulating factor=G-CSF
    °ú¸³±¸Áý¶ôÀÚ±ØÀÎÀÚ
  • granulocyte source
    °ú¸³±¸¿øÃµ<--±Ù¿ø
  • granulocyte transfusion
    °ú¸³¼¼Æ÷ ¼öÇ÷
  • granulocyte-erythrocyte antigens
    °ú¸³±¸ÀûÇ÷±¸Ç׿ø
  • granulocyte-macrophage coloneystimulating factor(gm-csf)
    °ú¸³±¸-´ë½Ä±¸ Áý¶ô ÀÚ±ØÀÎÀÚ
  • granulocyte-macrophage colony- stimulating factor
    °ú¸³±¸´ë½Ä¼¼Æ÷Áý¶ôÀÚ±ØÀÎÀÚ
  • granulocyte-macrophage colony-stimulating factor=GM-CSF
    °ú¸³±¸-´ë½Ä¼¼Æ÷Áý¶ôÀÚ±ØÀÎÀÚ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • abnormal localization of immature precursor cells=ALIP
    ¹Ì¼º¼÷Àü±¸¼¼Æ÷ÀÇ ºñÁ¤»ó ±¹Àç
  • thymic precursor cells
  • cell, precursor
    Àü±¸¼¼Æ÷
  • enzyme precursor
    È¿¼ÒÀü±¸Ã¼.
  • inactive precursor
    ºñȰ¼º Àü±¸¹°Áú.
  • basophilic granulocyte
    È£¿°±â¼º °ú¸³¹éÇ÷±¸
  • basophilic granulocyte
    È£¿°¼º(û¿ç¤àõ) °ú¸³±¸(ΨأϹ)
  • circulating granulocyte pool
    ¼øÈ¯ °ú¸³¹éÇ÷±¸ Ǫ¿ï
  • eosinophilic granulocyte
    È£»ê¼º °ú¸³±¸
  • eosinophilic granulocyte
    È£»ê±¸¼º °ú¸³±¸
  • granulocyte
    °ú¸³±¸
  • granulocyte
    °ú¸³¹éÇ÷__¡­ÛÜúìϹ), °ú¸³__
  • granulocyte colony-stimulating factor
    °ú¸³±¸Áý¶ôÀÚ±ØÀÎÀÚ
  • granulocyte colony-stimulating factor=G-CSF
    °ú¸³±¸Áý¶ôÀÚ±ØÀÎÀÚ
  • granulocyte source
    °ú¸³±¸¿øÃµ<--±Ù¿ø
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Tympanic air cells
    °í½Ç¹úÁý
    [¿¾ ¿ë¾î] °í½ÇºÀ¼Ò
  • Tympanic cells
    °í½Ç¹úÁý
    [¿¾ ¿ë¾î] °í½ÇºÀ¼Ò
  • Air cells of auditory tube
    ±ÍÀεΰü¹úÁý
    [¿¾ ¿ë¾î] À̰üºÀ¼Ò
  • Mastoid air cells
    ²ÀÁö¹úÁý
    [¿¾ ¿ë¾î] À¯µ¹ºÀ¼Ò
  • Mastoid cells
    ²ÀÁö¹úÁý
    [¿¾ ¿ë¾î] À¯µ¹ºÀ¼Ò
  • Ethmoidal cells
    ¹úÁý
    [¿¾ ¿ë¾î] »ç°ñºÀ¼Ò
  • Epithelial cells
    »óÇǼ¼Æ÷
    [¿¾ ¿ë¾î] »óÇǼ¼Æ÷
  • Anterior cells
    ¾Õ¹úÁý
    [¿¾ ¿ë¾î] ÀüºÀ¼Ò
  • Spermatogenic cells
    Á¤Àڹ߻ý¼¼Æ÷
    [¿¾ ¿ë¾î] Á¤¼¼Æ÷
  • Connective tissue cells
    °áÇÕÁ¶Á÷¼¼Æ÷
    [¿¾ ¿ë¾î] °áÇÕÁ¶Á÷¼¼Æ÷
  • Posterior cells
    µÚ¹úÁý
    [¿¾ ¿ë¾î] ÈĺÀ¼Ò
  • Middle cells
    Áß°£¹úÁý
    [¿¾ ¿ë¾î] ÁߺÀ¼Ò
  • Blood cells
    Ç÷¾×¼¼Æ÷ [Ç÷±¸]
    [¿¾ ¿ë¾î] Ç÷¾×¼¼Æ÷
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • endothelial cells
    ³»ÇǼ¼Æ÷ (Ò®ù«á¬øà)
  • HeLa cells
    HeLa ¼¼Æ÷(á¬øà)
  • killer T cells
    »ì(߯) T¼¼Æ÷(á¬øà)
  • Kupffer cells
    ÄíÆÛ ¼¼Æ÷(á¬øà)
  • precursor fragments
    Àü±¸¹°(îñÏÌÚª) Á¶°¢
  • precursor of serum prothrombin conversion accelerator
    Ç÷û(úìôè)ÇÁ·ÎÆ®·Òºó Àüȯ°¡¼ÓÁ¦ Àü±¸¹°Áú(ï®üµÊ¥áÜð¥îñÏÌÚªòõ)
  • precursor ribosomal RNA
    ¶óÀ̺¸¼Ø RNA
  • precursor transfer RNA
    Àü´Þ(îîÓ¹) RNA Àü±¸Ã¼(îñÏÌô÷)
  • regulatory T cells
    Á¶Àý(ðàï½) T¼¼Æ÷(á¬øà)
  • ribosomal precursor RNA
    ¶óÀ̺¸¼Ø Àü±¸(îñÏÌ) RNA
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • ethmoidal air cells
    »ç°ñ¹úÁý, »ç°ñºÀ¼Ò
  • precursor
    Àü±¸Ã¼, Àü±¸ ¹°Áú, Àü´Ü°è¹°Áú
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
APP acute phase protein; alum-precipitated pyridine; aminopyrazolopyrimidine; amyloid peptide precursor;...
ECP ectrodactyly-cleft palate [syndrome]; effector cell precursor; endocardial potential; eosinophil cat...
MGP marginal granulocyte pool; marginating granulocyte pool; membranous glomerulonephropathy; mucin glyc...
LAK T cells Lymphokine Activated Killer T cells
SRC sedimented red cells; sheep red cells
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
GM-CSF Granulocyte colony-stimulating factor , granulocyte-macrophage colony-stimulating factor
G-CSF Granulocyte-Macrophage Colony-Stimulating Factor , Granulocyte Colony-Stimulating Factor
GM-CFC Granulocyte macrophage colony-forming cells
CHO-cells Chinese Hamster Ovary cells
PC12 cells phaeochromocytoma cells
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • Rouget's cells
    Rouget ¼¼Æ÷
  • amine precursor uptake
    ¾Æ¹Î Àü±¸Ã¼ Èí¼ö
  • cartilagenous precursor
    ¿¬°ñ Àü±¸Ã¼
    ¿¬°ñÀÇ ¼±ÇàÇÏ´Â ¹°Áú·Î¼­, »ý¹°ÇÐÀû °úÁ¤¿¡ À־ Åë»óÀûÀ¸·Î ¿¬°ñ·ÎºÎÅÍ È°¼ºµµ°¡ ´õ ³ôµç°¡ º¸´Ù ¼º¼÷µÈ ¹°ÁúÀÌ »ý¼ºµÈ´Ù.
  • enzyme precursor
    È¿¼Ò Àü±¸Ã¼
  • phylogenetic precursor
    °èÅë ¹ß»ýÇÐÀû Àü±¸ ¹°Áú
  • precursor
    Àü±¸Ã¼, Àü±¸ ¹°Áú, Àü´Ü°è ¹°Áú
  • precursor peptide
    Àü±¸ ÆéƼµå
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
Amine Precursor Uptake and Decarboxylation <pharmacology, physiology> Paracrine cells of which argentaffin cells are an example. Usage of the term APUD is neither helpful nor memorable.
Acronym: APUD
(11 Nov 1997)
amyloid beta-protein precursor A precursor to the amyloid-beta protein (beta/a4). Alterations in the expression of the amyloid beta-protein precursor (abpp) gene, located on chromosome 21, plays a role in the development of the neuropathology common to both alzheimer disease and down syndrome. Abpp is associated with the extensive extracellular matrix secreted by neuronal cells. Upon cleavage, this precursor produces three proteins of varying amino acid lengths: 695, 751, and 770. The beta/a4 (695 amino acids) or beta-amyloid protein is the principal component of the extracellular amyloid in senile plaques found in alzheimer disease, down syndrome and, to a limited extent, in normal aging.
(12 Dec 1998)
amyloid precursor protein <protein> Individuals with Alzheimer's disease are characterised by extensive accumulation of amyloid in the brain, referred to as senile plaques. These consist of a core of amyloid fibrils surrounded by dystrophic neurites. The principal component of the amyloid fibrils is B/A4, a peptide derived from the larger APP. The specific role of amyloid protein is unclear but it is thought that amyloid deposits may cause neurons to degenerate. Amyloid deposits also occur in brains of older Down's Syndrome patients.
(04 May 1997)
angiotensin precursor angiotensin
receptors, granulocyte-colony-stimulating factor Receptors that bind and internalise granulocyte-colony-stimulating factor. Their mw is believed to be 150 kD. These receptors are found mainly on a subset of myelomonocytic cells.
(12 Dec 1998)
receptors, granulocyte-macrophage colony-stimulating factor Receptors that bind and internalise the granulocyte-macrophage stimulating factor. Their mw is believed to be 84 kD. The most mature myelomonocytic cells, specifically human neutrophils, macrophages, and eosinophils, express the highest number of affinity receptors for this growth factor.
(12 Dec 1998)
granulocyte <haematology> Leucocyte with conspicuous cytoplasmic granules. In humans the granulocytes are also classified as polymorphonuclear leucocytes and are subdivided according to the staining properties of the granules into eosinophils, basophils and neutrophils (using a Romanovsky type stain), some invertebrate blood cells are also referred to, not very helpfully, as granulocytes.
(12 Dec 1998)
granulocyte-colony-stimulating factor <growth factor, haematology, oncology> A glycoprotein of 25 kD containing internal disulfide bonds.
It induces the survival, proliferation, and differentiation of neutrophilic granulocyte precursor cells and functionally activates mature blood neutrophils. Among the family of colony-stimulating factors, G-CSF is the most potent inducer of terminal differentiation to granulocytes and macrophages of leukaemic myeloid cell lines.
A protein that stimulates the growth and maturation of granulocytes. It is used to promote the recovery of the white cells following chemotherapy.
See: colony-stimulating factor.
Acronym: G-CSF
(12 Dec 1998)
granulocyte-macrophage colony-stimulating factor <growth factor, haematology, oncology> An acidic glycoprotein of mw 23 kD with internal disulfide bonds.
It is produced in response to a number of inflammatory mediators by mesenchymal cells present in the haemopoietic environment and at peripheral sites of inflammation.
It stimulates the production of neutrophilic granulocytes, macrophages, and mixed granulocyte-macrophage colonies from bone marrow cells and can stimulate the formation of eosinophil colonies from foetal liver progenitor cells. It also has some functional activities in mature granulocytes and macrophages.
It is used to promote the recovery of the white blood cells following chemotherapy.
Chemical name: Colony-stimulating factor 2
See: colony-stimulating factor.
Acronym: GM-CSF
(12 Dec 1998)
precursor Something that precedes.
1. <biochemistry> In biological processes, a substance from which another, usually more active or mature substance is formed.
2. In clinical medicine, a sign or symptom that heralds another.
Origin: L. Praecursor = a forerunner
(18 Nov 1997)
immature granulocyte An immature neutrophil, except that it may be neutrophilic, acidophilic, or basophilic in character.
(05 Mar 2000)
enzyme precursor <biochemistry> Inactive precursors that can be converted to active enzymes.
Enzyme precursors containing extra-long polypeptide chains that block activity are activated by acid or enzymatic hydrolysis to remove the inhibiting portion.
(12 Dec 1998)
absorptive cells of intestine Cell's on the surface of villi of the small intestine and the luminal surface of the large intestine that are characterised by having microvilli on their free surface.
(05 Mar 2000)
air cells Air-containing spaces in the skull.
See: pulmonary alveolus.
(05 Mar 2000)
air cells of auditory tube Occasional small air cells in the inferior wall of the auditory tube, near the tympanic orifice, communicating with the tympanic cavity.
Synonym: cellulae pneumaticae tubae auditivae, air cells of auditory tube.
(05 Mar 2000)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 1 ÆäÀÌÁö: 1
  • Granulocyte Precursor Cells - »õâ The cells in the granulocytic series that give rise to mature granulocytes (NEUTROPHILS; EOSINOPHILS; and BASOPHILS.) These precursor cells include myeloblasts, promyelocytes, myelocytes and metamyelocytes.
    Synonyms : Granulocytic Precursor Cells, Metamyelocytes, Myeloblast, Myelocytes, Premyelocytes, Progranulocytes, Cell, Granulocyte Precursor, Cell, Granulocytic Precursor, Cells, Granulocyte Precursor, Cells, Granulocytic Precursor, Granulocyte Precursor Cell, Metamyelocyte
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • granulocyte
    °ú¸³¼º ¹éÇ÷±¸;°ú¸³±¸
  • gray cells
    ³ú;³ú¼ö;µÎ³ú;Áö´É;Áö¼º
  • precursor
    ¼±±¸ÀÚ
  • precursor
    ¼±±¸ÀÚ;¼±¹è;ÀüÁ¶ 
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á